Skip to main content

Table 2 Clinicopathologic features according to whether vagotomy was performed or the reason for palliative surgery

From: Is vagotomy necessary in palliative surgery for incurable advanced gastric cancer?: a retrospective case–control study

Variables

Description

PGJ (n = 46)

PGJV (n = 38)

P value

LUGC (n = 22)

GCDM (n = 62)

P value

Age

 < 65

19 (41.3)

19 (50.0)

0.425

8 (36.4)

30 (48.4)

0.330

 ≥ 65

27 (58.7)

19 (50.0)

 

14 (63.6)

32 (51.6)

 

Sex

Female

35 (76.1)

30 (78.9)

0.755

17 (77.3)

48 (77.4)

0.989

Male

11 (23.9)

8 (21.1)

 

5 (22.7)

14 (22.6)

 

Palliative chemotherapy

Not done

16 (34.8)

10 (26.3)

0.403

9 (40.9)

17 (27.4)

0.240

Done

30 (65.2)

28 (73.7)

 

13 (59.1)

45 (72.6)

 

Histologic type

Adenocarcinoma

38 (82.6)

28 (73.7)

0.321

17 (77.3)

49 (79.0)

0.863

Poorly cohesive

8 (17.4)

10 (26.3)

 

5 (22.7)

13 (21.0)

 

Albumin

 < 3.5 g/dL

31 (67.4)

21 (55.3)

0.255

13 (59.1)

39 (62.9)

0.752

 ≥ 3.5 g/dL

15 (32.6)

17 (44.7)

 

9 (40.9)

23 (37.1)

 

Comorbidity

 < 3

40 (87.0)

33 (86.8)

0.988

19 (86.4)

54 (87.1)

0.930

 ≥ 3

6 (13.0)

5 (13.2)

 

3 (13.6)

8 (12.9)

 

Approach method

Open

25 (54.3)

20 (52.6)

0.875

13 (59.1)

32 (51.6)

0.546

Laparoscopy

21 (45.7)

18 (47.4)

 

9 (40.9)

30 (48.4)

 

Vagotomy

None

   

12 (54.5)

34 (54.8)

0.981

Positive

   

10 (45.5)

28 (45.2)

 

Reason for gastrojejunostomy

LUGC

34 (73.9)

28 (73.7)

0.981

   

GCDM

12 (26.1)

10 (26.3)

    
  1. Abbreviations: PGJ Simple palliative gastrojejunostomy, PGJV Palliative gastrojejunostomy with vagotomy, LUGC Locally unresectable gastric cancer, GCDM Gastric cancer with distant metastasis
  2. All values are presented as frequency (percentage)
  3. p values were obtained using the chi-square test